Cargando…
P1161: ASPEN: LONG-TERM FOLLOW-UP RESULTS OF A PHASE 3 RANDOMIZED TRIAL OF ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR) IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM)
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430776/ http://dx.doi.org/10.1097/01.HS9.0000847512.47964.b7 |
| _version_ | 1784779869675061248 |
|---|---|
| author | Dimopoulos, M. Opat, S. D’Sa, S. Jurczak, W. Lee, H.-P. Cull, G. Owen, R. G. Marlton, P. Wahlin, B. E. Garcia-Sanz, R. McCarthy, H. Mulligan, S. Tedeschi, A. Castillo, J. J. Czyz, J. Fernandez De Larrea Rodriguez, C. Belada, D. Libby, E. Matous, J. Motta, M. Siddiqi, T. Tani, M. Trneny, M. Minnema, M. Buske, C. Leblond, V. Treon, S. P. Trotman, J. Chan, W. Y. Schneider, J. Allewelt, H. Cohen, A. Huang, J. Tam, C. S. |
| author_facet | Dimopoulos, M. Opat, S. D’Sa, S. Jurczak, W. Lee, H.-P. Cull, G. Owen, R. G. Marlton, P. Wahlin, B. E. Garcia-Sanz, R. McCarthy, H. Mulligan, S. Tedeschi, A. Castillo, J. J. Czyz, J. Fernandez De Larrea Rodriguez, C. Belada, D. Libby, E. Matous, J. Motta, M. Siddiqi, T. Tani, M. Trneny, M. Minnema, M. Buske, C. Leblond, V. Treon, S. P. Trotman, J. Chan, W. Y. Schneider, J. Allewelt, H. Cohen, A. Huang, J. Tam, C. S. |
| author_sort | Dimopoulos, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430776 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94307762022-08-31 P1161: ASPEN: LONG-TERM FOLLOW-UP RESULTS OF A PHASE 3 RANDOMIZED TRIAL OF ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR) IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) Dimopoulos, M. Opat, S. D’Sa, S. Jurczak, W. Lee, H.-P. Cull, G. Owen, R. G. Marlton, P. Wahlin, B. E. Garcia-Sanz, R. McCarthy, H. Mulligan, S. Tedeschi, A. Castillo, J. J. Czyz, J. Fernandez De Larrea Rodriguez, C. Belada, D. Libby, E. Matous, J. Motta, M. Siddiqi, T. Tani, M. Trneny, M. Minnema, M. Buske, C. Leblond, V. Treon, S. P. Trotman, J. Chan, W. Y. Schneider, J. Allewelt, H. Cohen, A. Huang, J. Tam, C. S. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430776/ http://dx.doi.org/10.1097/01.HS9.0000847512.47964.b7 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Dimopoulos, M. Opat, S. D’Sa, S. Jurczak, W. Lee, H.-P. Cull, G. Owen, R. G. Marlton, P. Wahlin, B. E. Garcia-Sanz, R. McCarthy, H. Mulligan, S. Tedeschi, A. Castillo, J. J. Czyz, J. Fernandez De Larrea Rodriguez, C. Belada, D. Libby, E. Matous, J. Motta, M. Siddiqi, T. Tani, M. Trneny, M. Minnema, M. Buske, C. Leblond, V. Treon, S. P. Trotman, J. Chan, W. Y. Schneider, J. Allewelt, H. Cohen, A. Huang, J. Tam, C. S. P1161: ASPEN: LONG-TERM FOLLOW-UP RESULTS OF A PHASE 3 RANDOMIZED TRIAL OF ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR) IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) |
| title | P1161: ASPEN: LONG-TERM FOLLOW-UP RESULTS OF A PHASE 3 RANDOMIZED TRIAL OF ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR) IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) |
| title_full | P1161: ASPEN: LONG-TERM FOLLOW-UP RESULTS OF A PHASE 3 RANDOMIZED TRIAL OF ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR) IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) |
| title_fullStr | P1161: ASPEN: LONG-TERM FOLLOW-UP RESULTS OF A PHASE 3 RANDOMIZED TRIAL OF ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR) IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) |
| title_full_unstemmed | P1161: ASPEN: LONG-TERM FOLLOW-UP RESULTS OF A PHASE 3 RANDOMIZED TRIAL OF ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR) IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) |
| title_short | P1161: ASPEN: LONG-TERM FOLLOW-UP RESULTS OF A PHASE 3 RANDOMIZED TRIAL OF ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR) IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) |
| title_sort | p1161: aspen: long-term follow-up results of a phase 3 randomized trial of zanubrutinib (zanu) vs ibrutinib (ibr) in patients (pts) with waldenström macroglobulinemia (wm) |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430776/ http://dx.doi.org/10.1097/01.HS9.0000847512.47964.b7 |
| work_keys_str_mv | AT dimopoulosm p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT opats p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT dsas p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT jurczakw p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT leehp p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT cullg p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT owenrg p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT marltonp p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT wahlinbe p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT garciasanzr p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT mccarthyh p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT mulligans p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT tedeschia p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT castillojj p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT czyzj p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT fernandezdelarrearodriguezc p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT beladad p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT libbye p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT matousj p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT mottam p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT siddiqit p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT tanim p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT trnenym p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT minnemam p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT buskec p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT leblondv p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT treonsp p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT trotmanj p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT chanwy p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT schneiderj p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT allewelth p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT cohena p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT huangj p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm AT tamcs p1161aspenlongtermfollowupresultsofaphase3randomizedtrialofzanubrutinibzanuvsibrutinibibrinpatientsptswithwaldenstrommacroglobulinemiawm |